Title of article :
COVID-19 in heart transplant recipients
Author/Authors :
Taghavi ، Sepideh Heart Valve Disease Research Center, Rajaie Cardiovascular Medical and Research Center - Iran University of Medical Sciences , Raffiei Jelodar ، Hoda Rajaie Cardiovascular Medical and Research Center - Iran University of Medical Sciences , Rafati ، Ali Heart Valve Disease Research Center, Rajaie Cardiovascular Medical and Research Center - Iran University of Medical Sciences , Naderi ، Nasim Rajaie Cardiovascular Medical and Research Center - Iran University of Medical Sciences , Mirtajaddini ، Marzieh Rajaie Cardiovascular Medical and Research Center - Iran University of Medical Sciences , Amin ، Ahmad Rajaie Cardiovascular Medical and Research Center - Iran University of Medical Sciences , Valizadeh ، Leili Rajaie Cardiovascular Medical and Research Center - Iran University of Medical Sciences , Omidvar ، Razieh Rajaie Cardiovascular Medical and Research Center - Iran University of Medical Sciences , Kamali ، Monireh Rajaie Cardiovascular Medical and Research Center - Iran University of Medical Sciences , Naseh ، Soroush University of Auckland
Abstract :
Introduction: After solid organ transplantation, patients require lifelong immunosuppressive medication, increasing susceptibility to COVID-19. We evaluated the clinical outcomes of heart transplant recipients in patients with COVID-19. Methods: We enrolled twenty-two COVID-19 cases of adult heart transplantation from February 2020 to September 2021. Results: The most common symptoms in patients were fever and myalgia. The death occurred in 3 (13.6 %). Conclusion: Although heart transplantation mortality may increase in the acute rejection phase concomitant with COVID-19, immunosuppressive dose reduction may not be necessary for all heart transplant patients with COVID-19.
Keywords :
SARS , CoV , 2 , COVID , 19 , Heart Transplantation , Immunosuppressive Medication
Journal title :
Journal of Cardiovascular and Thoracic Research (JCVTR)
Journal title :
Journal of Cardiovascular and Thoracic Research (JCVTR)
